Double-blind comparison of trovafloxacin and doxycycline in the treatment of uncomplicated Chlamydial urethritis and cervicitis. Trovafloxacin Chlamydial Urethritis/Cervicitis Study Group

Clicks: 421
ID: 112866
1999
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Trovafloxacin given once daily for 5 days was clinically and bacteriologically equivalent to doxycycline given twice daily for 7 days in women with uncomplicated chlamydial cervicitis. This equivalence was not demonstrated in men with uncomplicated chlamydial urethritis.
Reference Key
wm1999sexuallydouble-blind Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors McCormack WM;Dalu ZA;Martin DH;Hook EW;Laisi R;Kell P;Pluck ND;Johnson RB;;
Journal Sexually Transmitted Diseases
Year 1999
DOI
DOI not found
URL
http://www.ncbi.nlm.nih.gov/pubmed/10534208
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE humans pubmed abstract nih national institutes of health national library of medicine adult female male adolescent aged middle aged Comparative Study sex factors Clinical Trial Randomized Controlled Trial Double-Blind Method Multicenter Study anti-bacterial agents / adverse effects fluoroquinolones* anti-bacterial agents / administration & dosage anti-bacterial agents / therapeutic use* chlamydia infections / drug therapy* doxycycline / adverse effects doxycycline / therapeutic use* pmid:10534208 doi:10.1097/00007435-199910000-00009 w m mccormack z a dalu r b johnson anti-infective agents / adverse effects anti-infective agents / therapeutic use* chlamydia trachomatis* doxycycline / administration & dosage naphthyridines / adverse effects naphthyridines / therapeutic use* urethritis / drug therapy* urethritis / microbiology uterine cervicitis / drug therapy* uterine cervicitis / microbiology

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.